Pharmacy in Canada
Bookmark / Share
Email This

Communications with Government

It is crucial for pharmacists to be involved when governments are making decisions that affect our profession and the health and safety of Canadians. CPhA is dedicated to ensuring that pharmacists’ voices are heard. We communicate with all levels of government on a regular basis, submitting position statements, offering support and presenting to senate committees on issues that are important to you.

October 2014
Bill C-17, An Act to Amend the Food and Drugs Act (Vanessa's Law) Senate Committee
Perry Eisenschmid, the Canadian Pharmacists Association's Chief Executive Officer, and Janet Cooper, Vice President, Professional and Membership Affairs, presented to the Senate Social Affairs, Science, and Technology Committee on proposed amendments to the Food and Drug Act known as Bill C-17.
Read the speaking notes in English
En francais

August 2014
Controlled Drugs and Substances Act re: tamper-resistant properties
CPhA presented a submission to Health Canada as part of its consultation on possible regulations to the Controlled Drugs and Substances Act regarding tamper resistant properties.
Read the submission
Read more about prescription drug abuse

June 2014
Prescription pharmaceuticals
Perry Eisenschmid, the Canadian Pharmacists Association's Chief Executive Officer, appeared before the Senate Social Affairs, Science, and Technology Committee for a roundtable on prescription pharmaceuticals in Canada.
Read more

June 2014
Bill C-17, An Act to Amend the Food and Drugs Act (Vanessa’s Law) House of Commons Committee
Jeff Morrison, Director, Government Relations and Public Affairs, and Barry Power, consultant, discussed Bill C-17, An Act to Amend the Food and Drugs Act (Vanessa’s Law), with the House of Commons Standing Committee on Health.
Read more

April 2014
Study of the Best Practices and Federal Barriers Related to the Scope of Practice and Skills Training of Healthcare Professionals
Speaking notes to the House of Commons Standing Committee on Health
Official transcript of the proceedings, April 10, 2014

March 2014
Study on prescription pharmaceuticals in Canada — the nature of unintended consequences
Speaking notes to the Senate Committee on Social Affairs, Science and Technology
Official transcript of the proceedings, March 26, 2014

December 2013
Prescription drug abuse
Speaking notes to the House of Commons Standing Committee on Health
Official transcript of the proceedings, December 2, 2013

March 2013
Alberta Government Cuts to Generic Drug Prices
CPhA letter to Alberta Minister of Health re: Budget cuts to generic drug prices

March 2013
Marihuana for Medical Purposes Regulations (MMPR) consultations
CPhA's response to proposed Marihuana for Medical Purposes Regulations

February 2013
Off-label use of prescription drugs
Speaking notes to the Senate Committee on Social Affairs, Science, and Technology
Offical transcript of the proceedings, February 27, 2013

May 2012
Cancellation of supplemental health benefits under the Interim Federal Health Program
Joint letter to Hon. Jason Kenney opposing cancellation of benefits

October 2011
Reviewing the 2004 Health Accord
Submission to the Senate Committee on Social Affairs, Science, and Technology

October 2011
Study on chronic disease and aging
Submission to the House of Commons Standing Committee on Health

August 2011
Pre-budget consultations
Submission to the House of Commons Finance Committee

July 2011
Medical Marihuana Consultations
Comments to Health Canada on the consultation document "Proposed
Improvements to Health Canada's Marihuana Medical Access Program"

December 2010
Application of GST/HST to professional non-dispensing pharmacy services
CPhA's request to Canada Revenue Agency for clarification of the issue
Canada Revenue Agency's Response to CPhA

October 2010
The role of pharmacists in the H1N1 pandemic and recommendations on how to improve future pandemic
Opening remarks and written brief to the Senate Committee on Social Affairs, Science and Technology

September 2010
Pan-Canadian bulk purchasing arrangement for common drugs
First Ministers’ announcement
CPhA Response to Premiers (en français)
CPhA Position Paper (2005)

August 2010
Pre-budget consultations
Submission to the House of Commons Standing Committee on Finance

July 2010
Mandatory census long form
Letter to Hon. Tony Clement

May 2010
DIDFA
CPhA Response to the Government of Ontario’s proposed regulatory changes to the
Drug Interchangeability and Dispensing Fee Act

May 2008
Review of the 10-Year Plan to Strengthen Health Care
Submission to the House of Commons Standing Committee on Health (en français)

February 2008
Post-market surveillance
Presentation to House of Commons Standing Committee on Health (en français)

March 2007
Cross-border prescription drug trade
Joint submission to the US Senate Sub-Committee

November 2006
Bill 41 – The Pharmaceutical Act
CPhA Letter of Support

November 2006
Cross-Border Prescription Drug Trade
Joint letter to Hon. Tony Clement (CPhA, OPA, CAPDM, BMC)
Joint Position Statement (CPhA, OPA, CAPDM, BMC)

November 2006
TDSPA
Submission to the Ontario Ministry of Long Term Care
Joint letter to Ontario Premier (CPhA, CACDS, CAPDM-Rx&D)